You are here: Industry Insights > COVID-19

News List

Impact of COVID-19 on clinical trials continuing, say researchers europeanpharmaceuticalreview
September 14, 2020
An analysis of the impact of COVID-19 on clinical trials has shown this is increasing, with many sites unable to fully resume practice.
NIHR, UKRI fund eight new coronavirus research projects pharmatimes
September 14, 2020
Eight new research projects investigating the transmission of coronavirus have been awarded a total of ￡5.3 million by the NIHR and UK Research and Innovation (UKRI), in the hope that findings will help shape COVID-19 policy decisions on prevention and...
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients expresspharma
September 14, 2020
A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support.
Patient activist groups express relief over pause of Covishield trials in India expresspharma
September 14, 2020
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety.
Health Highlights: Sept. 9, 2020 drugs.com
September 10, 2020
The coronavirus pandemic threatens decades of progress in reducing preventable deaths in children worldwide, a new United Nations/ World Bank paper warns.
Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme pharmaceutical-business-review
September 08, 2020
Twist Bioscience announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G (IgG) antibodies and substantially smaller single domain VHH “nanobodies,” against SARS-CoV-2, the virus ...
$3.7 Billion Worldwide Hemostasis Diagnostics Industry to 2027 - Impact of COVID-19 on the Market prnewswire
September 08, 2020
?Amid the COVID-19 crisis, the global market for Hemostasis Diagnostics estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.
UK to invest ￡500 million in next generation COVID-19 testing europeanpharmaceuticalreview
September 08, 2020
Matt Hancock has announced that the ￡500 million investment will go towards new COVID-19 testing technologies and increased testing capacity.
Inhaled ensifentrine will be assessed in hospitalised patients pharmatimes
September 08, 2020
Verona Pharma has kicked off a pilot study to investigate the efficacy and safety of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19.
Destiny, SporeGen collaborate on COVID-19 prevention spray pharmatimes
September 08, 2020
UK biotechs Destiny Pharma and SporeGen have entered into a collaborative agreement to develop a new preventative treatment for COVID-19, with support from an ￡800,000 grant from Innovate UK.